rs202132697
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012293.3(PXDN):c.3190G>A(p.Ala1064Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00239 in 1,609,374 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 7 hom. )
Consequence
PXDN
NM_012293.3 missense
NM_012293.3 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 4.77
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.034437597).
BP6
Variant 2-1648590-C-T is Benign according to our data. Variant chr2-1648590-C-T is described in ClinVar as [Benign]. Clinvar id is 217340.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-1648590-C-T is described in Lovd as [Likely_benign]. Variant chr2-1648590-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00167 (247/147952) while in subpopulation SAS AF= 0.00282 (13/4602). AF 95% confidence interval is 0.00238. There are 0 homozygotes in gnomad4. There are 107 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PXDN | NM_012293.3 | c.3190G>A | p.Ala1064Thr | missense_variant | 17/23 | ENST00000252804.9 | NP_036425.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PXDN | ENST00000252804.9 | c.3190G>A | p.Ala1064Thr | missense_variant | 17/23 | 1 | NM_012293.3 | ENSP00000252804 | P1 | |
PXDN | ENST00000478155.5 | n.2697-3838G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00167 AC: 247AN: 147820Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
247
AN:
147820
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00183 AC: 455AN: 248828Hom.: 2 AF XY: 0.00179 AC XY: 242AN XY: 134962
GnomAD3 exomes
AF:
AC:
455
AN:
248828
Hom.:
AF XY:
AC XY:
242
AN XY:
134962
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00247 AC: 3605AN: 1461422Hom.: 7 Cov.: 31 AF XY: 0.00251 AC XY: 1827AN XY: 726974
GnomAD4 exome
AF:
AC:
3605
AN:
1461422
Hom.:
Cov.:
31
AF XY:
AC XY:
1827
AN XY:
726974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00167 AC: 247AN: 147952Hom.: 0 Cov.: 33 AF XY: 0.00148 AC XY: 107AN XY: 72218
GnomAD4 genome
AF:
AC:
247
AN:
147952
Hom.:
Cov.:
33
AF XY:
AC XY:
107
AN XY:
72218
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
31
ExAC
AF:
AC:
230
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PXDN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 13, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Anterior segment dysgenesis 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2021 | - - |
Developmental cataract Benign:1
Likely benign, no assertion criteria provided | research | Eye Genetics Research Group, Children's Medical Research Institute | Jan 09, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
M
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at